ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106. A total of 172 filers reported holding ANTARES PHARMA INC in Q1 2021. The put-call ratio across all filers is 0.48 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $70,000 | +14.8% | 17,161 | 0.0% | 0.00% | – |
| Q4 2021 | $61,000 | -1.6% | 17,161 | 0.0% | 0.00% | – |
| Q3 2021 | $62,000 | +26.5% | 17,161 | +51.7% | 0.00% | – |
| Q2 2021 | $49,000 | +6.5% | 11,316 | +0.1% | 0.00% | – |
| Q1 2021 | $46,000 | -29.2% | 11,309 | -30.9% | 0.00% | – |
| Q4 2020 | $65,000 | +32.7% | 16,359 | -10.4% | 0.00% | – |
| Q3 2020 | $49,000 | +53.1% | 18,265 | +52.2% | 0.00% | – |
| Q2 2020 | $32,000 | – | 12,002 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sargent Investment Group, LLC | 4,598,329 | $10,852,000 | 4.99% |
| Soleus Capital Management, L.P. | 864,100 | $2,039,000 | 2.37% |
| Healthcare Value Capital, LLC | 500,000 | $1,180,000 | 1.98% |
| ORACLE INVESTMENT MANAGEMENT INC | 1,227,114 | $2,896,000 | 0.86% |
| PERKINS CAPITAL MANAGEMENT INC | 232,166 | $548,000 | 0.66% |
| Stonepine Capital Management, LLC | 151,189 | $357,000 | 0.38% |
| Zebra Capital Management LLC | 84,963 | $200,000 | 0.32% |
| Intrinsic Edge Capital Management LLC | 1,000,000 | $2,360,000 | 0.31% |
| Alambic Investment Management, L.P. | 46,069 | $109,000 | 0.26% |
| OBERWEIS ASSET MANAGEMENT INC/ | 200,600 | $473,000 | 0.26% |